Fundraising FoxNovalis LifeSciences — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Everest Biolabseverestbiolabs.comin𝕏Feb 2026SEC filingmedium confidence
Everest Biolabs develops automated instruments, size-exclusion chromatography columns, and ELISA assays for extracellular vesicle (EV) isolation, concentration, and quantification.
BiotechDeep TechHardwareWaltham, US
George Daaboul(Executive Officer, Director)inDavid Freedman(Executive Officer, Director)
BoardVinit Nijhawan(Director)inDavid Walt(Director)
Board seatPaul Meister· per SEC Form D · $5.7M raise · filed Mar 2026
Co-investorsMassVentures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.